Table of Content

1. Introductions

2. Research & Methodology


3. Executive Summary

4. Global Diabetes Drug Market


5. Market Share – Global Diabetes Drug

5.1 By Disease Type
5.2 By Therapy – (Oral, Injection, Insulin)
5.3 By Oral Drug
5.4 By Injection Drug
5.5 By Insulin
5.6 By Regions – Type 1 Diabetes Drug
5.7 By Regions – Type 2 Diabetes Drug


6. Disease Type – Global Diabetes Drug Market

6.1 Type 1 Diabetes Drug Market
6.2 Type 2 Diabetes Drug Market


7. Global Diabetes Drug Market by Therapy

7.1 Oral

7.1.1 (DPP) IV inhibitor
7.1.2 SGLT-2
7.1.3 Alpha Glucosidase Inhibitor
7.1.4 Biguanide
7.1.5 Others Oral Drug

7.2 Injection

7.2.1 Glucagon-like peptide (GLP) 1 agonist
7.2.2 Amylin receptor against

7.3 Insulin

7.3.1 Rapid – Acting Insulin
7.3.2 Long Acting Insulin
7.3.3 Premixed Insulin
7.3.4 Other Insulin


8. Global Type 1 Diabetes Drug Market by Region

8.1 United States
8.2 5 European Union
8.3 Japan
8.4 Canada


9. Global Type 2 Diabetes Drug Market by Region

9.1 United States
9.2 5 European Union
9.3 Japan
9.4 China
9.5 India
9.6 Brazil


10. Global Type1 & Type 2 Diabetes Population Market by Region

10.1 United States Diabetes Population

10.1.1 Type1 Diabetes Population
10.1.2 Type 2 Diabetes Population

10.2 5European Union Diabetes Population

10.2.1 Type1 Diabetes Population
10.2.2 Type 2 Diabetes Population

10.3 Japan Diabetes Population

10.3.1 Type1 Diabetes Population
10.3.2 Type 2 Diabetes Population

10.4 Canada Diabetes Population

10.4.1 Type1 Diabetes Population
10.4.2 Type 2 Diabetes Population

10.5 China Diabetes Population

10.5.1 Type1 Diabetes Population
10.5.2 Type 2 Diabetes Population

10.6 India Diabetes Population

10.6.1 Type1 Diabetes Population
10.6.2 Type 2 Diabetes Population

10.7 Brazil Diabetes Population

10.7.1 Type1 Diabetes Population
10.7.2 Type 2 Diabetes Population


11. Merger & acquisitions


12. Market Dynamics

12.1 Growth Driver

12.1.1 The rising prevalence of Diabetes
12.1.2 The Rising Cost of Diabetes Care

12.2 Challenges

12.2.1 Diabetic Ketoacidosis
12.2.2 Severe Hypoglycemia
12.2.3 Weight Gain

12.3 Opportunities


13. Key Players Analysis

13.1 Novo Nordisk

13.1.1 Overview
13.1.2 R&D Pipeline
13.1.3 Sales Analysis

13.2 Merck & Co

13.2.1 Overview
13.2.2 R&D Pipeline
13.2.3 Sales Analysis

13.3 Eli Lilly

13.3.1 Overview
13.3.2 R&D Pipeline
13.3.3 Sales Analysis

13.4 AstraZeneca

13.4.1 Overview
13.4.2 R&D Pipeline
13.4.3 Sales Analysis

13.5 Johnson & Johnson

13.5.1 Overview
13.5.2 R&D Pipeline
13.5.3 Sales Analysis

13.6 Boehringer Ingelheim

13.6.1 Overview
13.6.2 R&D Pipeline
13.6.3 Sales Analysis

13.7 Others



List of Figures



Figure-01: Global – Diabetes Drugs Market size (Million US$), 2020 & 2026
Figure-02: Global – Diabetes Drugs Growing Segments
Figure-03: Global – Diabetes Drugs Market (Million US$), 2016 – 2019
Figure-04: Global – Forecast for Diabetes Drugs Market(Million US$), 2020 – 2026
Figure-05: Global – Diabetes Drugs Market Share by Disease type (Percent), 2016 – 2019
Figure-06: Global – Forecast for Diabetes Drugs Market Share by disease type(Percent), 2020 – 2026
Figure-07: Global – Diabetes Drugs Market Share by Therapy (Percent), 2016 – 2019
Figure-08: Global – Forecast for Diabetes Drugs Market Share by Therapy (Percent), 2020 – 2026
Figure-09: Global – Diabetes Drugs Market Share by Insulin (Percent), 2016 – 2019
Figure-10: Global – Forecast for Diabetes Drugs Market Share by Insulin (Percent), 2020 – 2026
Figure-11: Global – Type1 Diabetes Drug Market Share by Regions (Percent), 2016 – 2019
Figure-12: Global – Forecast for Type1 Diabetes Drug Market Share by Regions (Percent), 2020 – 2026
Figure-13: Global – Type1 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-14: Global – Forecast for Type1 Diabetes Drugs Market (Million US$), 2020 – 2026
Figure-15: Global – Type2 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-16: Global – Forecast for Type2 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-17: Global – Oral (DPP) IV Inhibitor Drug Market (Million US$), 2016 – 2019
Figure-18: Global – Forecast for Oral (DPP) IV Inhibitor Drug Market (Million US$), 2020 – 2026
Figure-19: Global – Oral SGLT-2 Drug Market (Million US$), 2016 – 2019
Figure-20: Global – Forecast for Oral SGLT-2 Drug Market (Million US$), 2020 – 2026
Figure-21: Global – Oral Alpha Glucosidase Inhibitor Drug Market (Million US$), 2016 – 2019
Figure-22: Global – Forecast for Oral Alpha Glucosidase Inhibitor Drug Market (Million US$), 2020 – 2026
Figure-23: Global – Oral Biguanide Drug Market (Million US$), 2016 – 2019
Figure-24: Global – Forecast for Oral Biguanide Drug Market (Million US$), 2020 – 2026
Figure-25: Global – Oral Others Drug Market (Million US$), 2016 – 2019
Figure-26: Global – Forecast for Oral Others Drug Market (Million US$), 2020 – 2026
Figure-27: Global – Diabetes Injectable Drug Glucagon-like peptide (GLP) 1 Agonist Market (Million US$), 2016 – 2019
Figure-28: Global – Forecast for Diabetes Injectable Drug Glucagon-like peptide (GLP) 1 agonist Market (Million US$), 2020 – 2026
Figure-29: Global – Diabetes Injectable Drug Amylin receptor agonist Market (Million US$), 2016 – 2019
Figure-30: Global – Forecast for Diabetes Injectable Drug Amylin receptor agonist Market (Million US$), 2020 – 2026
Figure-31: Global – Diabetes Insulin Drug Rapid Acting (Fast Acting) Market (Million US$), 2016 – 2019
Figure-32: Global – Forecast for Diabetes Insulin Drug Rapid Acting (Fast Acting) Market (Million US$), 2020 – 2026
Figure-33: Global – Diabetes Insulin Drug Long Acting Market (Million US$), 2016 – 2019
Figure-34: Global – Forecast for Diabetes Insulin Drug Long Acting Market (Million US$), 2020 – 2026
Figure-35: Global – Diabetes Insulin Drug Premixed Market (Million US$), 2016 – 2019
Figure-36: Global – Forecast for Diabetes Insulin Drug Premixed Market (Million US$), 2020 – 2026
Figure-37: Global – Diabetes Drug Other Insulin (Including Human Insulin) Market (Million US$), 2016 – 2019
Figure-38: Global – Forecast for Diabetes Drug Other Insulin (Including Human Insulin) Market (Million US$), 2020 – 2026
Figure-39: United States – Type1 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-40: United States – Forecast for Type1 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-41: 5 European Union – Type 1 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-42: 5 European Union – Forecast for type 1 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-43: Japan – Type1 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-44: Japan – Forecast for Type1 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-45: Canada – Type 1 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-46: Canada – Forecast for Type1 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-47: United States – Type2 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-48: United States – Forecast for Type2 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-49: 5 European Union – Type2 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-50: 5 European Union – Forecast for Type2 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-51: Japan – Type2 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-52: Japan – Forecast for Type2 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-53: China – Type2 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-54: China – Forecast for Type2 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-55: India – Type2 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-56: India – Forecast for Type2 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-57: Brazil – Type2 Diabetes Drug Market (Million US$), 2016 – 2019
Figure-58: Brazil – Forecast for Type2 Diabetes Drug Market (Million US$), 2020 – 2026
Figure-59: United States – Diabetes Population (Thousands), 2015 – 2019
Figure-60: United States – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-61: United States – Type1 Diabetes Population (Thousands), 2015 – 2019
Figure-62: United States – Forecast for Type1 Diabetes Population (Thousands), 2020 – 2026
Figure-63: United States – Type2 Diabetes Population (Thousands), 2015 – 2019
Figure-64: United States – Forecast for Type2 Diabetes Population (Thousands), 2020 – 2026
Figure-65: 5European Union – Diabetes Population (Thousands), 2015 – 2019
Figure-66: 5European Union – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-67: 5 European Union – Type1 Diabetes Population (Thousands), 2015 – 2019
Figure-68: 5 European Union – Forecast for Type1 Diabetes Population (Thousands), 2020 – 2026
Figure-69: 5European Union – Type2 Diabetes Population (Thousands), 2015 – 2019
Figure-70: 5European Union – Forecast for Type2 Diabetes Population (Thousands), 2020 – 2026
Figure-71: Japan – Diabetes Population (Thousands), 2015 – 2019
Figure-72: Japan – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-73: Japan – Type1 Diabetes Population (Thousands), 2015 – 2019
Figure-74: Japan – Forecast for Type1 Diabetes Population (Thousands), 2020 – 2026
Figure-75: Japan – Type2 Diabetes Population (Thousands), 2015 – 2019
Figure-76: Japan – Forecast for Type2 Diabetes Population (Thousands), 2020 – 2026
Figure-77: Canada – Diabetes Population (Thousands), 2015 – 2019
Figure-78: Canada – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-79: Canada – Type1 Diabetes Population (Thousands), 2015 – 2019
Figure-80: Canada – Forecast for Type1 Diabetes Population (Thousands), 2020 – 2026
Figure-81: Canada – Type2 Diabetes Population (Thousands), 2015 – 2019
Figure-82: Canada – Forecast for Type2 Diabetes Population (Thousands), 2020 – 2026
Figure-83: China – Diabetes Population (Thousands), 2015 – 2019
Figure-84: China – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-85: China – Type1 Diabetes Population (Thousands), 2015 – 2019
Figure-86: China – Forecast for Type1 Diabetes Population (Thousands), 2020 – 2026
Figure-87: China – Type2 Diabetes Population (Thousands), 2015 – 2019
Figure-88: China – Forecast for type2 Diabetes Population (Thousands), 2020 – 2026
Figure-89: India – Diabetes Population (Thousands), 2015 – 2019
Figure-90: India – Forecast for type2 Diabetes Population (Thousands), 2020 – 2026
Figure-91: India – Type1 Diabetes Population (Thousands), 2015 – 2019
Figure-92: India – Forecast for Type1 Diabetes Population (Thousands), 2020 – 2026
Figure-93: India – Type2 Diabetes Population (Thousands), 2015 – 2019
Figure-94: India – Forecast for Type2 Diabetes Population (Thousands), 2020 – 2026
Figure-95: Brazil – Diabetes Population (Thousands), 2015 – 2019
Figure-96: Brazil – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-97: Brazil – Diabetes Population (Thousands), 2015 – 2019
Figure-98: Brazil – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-99: Brazil – Diabetes Population (Thousands), 2015 – 2019
Figure-100: Brazil – Forecast for Diabetes Population (Thousands), 2020 – 2026
Figure-101: Global – Novo Nordisk Diabetes Drug Sales (Million US$), 2016 – 2019
Figure-102: Global – Forecast for Novo Nordisk Diabetes Drug Sales (Million US$), 2020 – 2026
Figure-103: Global – Merck & Co Diabetes Drug Sales (Million US$), 2016 – 2019
Figure-104: Global – Forecast for Merck & Co Diabetes Drug Sales (Million US$), 2020 – 2026
Figure-105: Global – Eli Lilly Diabetes Drug Sales (Million US$), 2016 – 2019
Figure-106: Global – Forecast for Eli Lilly Diabetes Drug Sales (Million US$), 2020 – 2026
Figure-108: Global – AstraZeneca Diabetes Drug Sales (Million US$), 2016 – 2019
Figure-109: Global – Forecast for AstraZeneca Diabetes Drug Sales (Million US$), 2020 – 2026
Figure-110: Global – Johnson & Johnson Diabetes Drug Sales (Million US$), 2015 – 2018
Figure-111: Global – Boehringer Ingelheim Diabetes Drug Sales (Million US$), 2015 – 2019
Figure-112: Global – Forecast for Boehringer Ingelheim Diabetes Drug Sales (Million US$), 2020 – 2026

 

List of Tables


List of Table:

Table-1: Global – Diabetes Drugs Market Share by Oral Drug (Percent), 2016 – 2019
Table-2: Global – Forecast for Diabetes Drugs Market Share by Oral Drug (Percent), 2020 – 2026
Table-3: Global – Diabetes Drugs Market Share by Injectable Drug (Percent), 2016 – 2019
Table-4: Global – Forecast for Diabetes Drugs Market Share by Injectable Drug (Percent), 2020 – 2026
Table-5: Global – Type2 Diabetes Drug Market Share by Regions (Percent), 2016 – 2019
Table-6: Global – Forecast for Type2 Diabetes Drug Market Share by Regions (Percent), 2020 – 2026
Table-7: Number of people with diabetes worldwide and per region in 2017 and 2045 (20-79 years)
Table-8: Top Therapeutic Classes By Invoice Spending